Novo Nordisk faces FDA scrutiny over unreported Ozempic side effects, including deaths and a suicide, amid struggles to compete with Eli Lilly in the US obesity drug market. Despite risks like nausea and pancreatitis, Ozempic helps control blood sugar, slow digestion, and reduce appetite.
Ozempic’s drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they?
